A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adults

Bullock, A; Gunduz-Bruce, H; Zammit, GK; Qin, M; Li, HH; Sankoh, AJ; Silber, C; Kanes, SJ; Jonas, J; Doherty, J

Bullock, A (通讯作者)，Sage Therapeut Inc, 215 First St, Cambridge, MA 02142 USA.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022; 37 (1):

Abstract

Objective To evaluate single zuranolone (SAGE-217) 30 or 45 mg doses in a 5-h phase advance insomnia model. Methods In this double-blind, three-way cr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索